Kam Lawrence’s Regenxbio RGNX Stock Holding History

Kam Lawrence’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$19.1M	Buy	+465,664	New	+$18.4M	19.59%	2

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Kam Lawrence's RGNX Position: Q4 2019 in Review

Kam Lawrence opened a new position in Regenxbio (RGNX) in Q4 2019: 465,664 shares worth $19.1M. The stake represents 19.59% of the portfolio and ranks #2 among its holdings.

187 funds tracked by Wall St. Rank hold RGNX as of Q4 2019.

Kam Lawrence held 465,664 shares of Regenxbio worth $19.1M as of Q4 2019.
Regenxbio was a new Kam Lawrence position in Q4 2019.
Regenxbio made up 19.59% of Kam Lawrence's portfolio in Q4 2019, its #2 holding.
187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2019.

Based on Kam Lawrence's 13F filing for Q4 2019, filed 13 Feb 2020.